Abstract Background Lipoprotein (a)(Lp [a]) has been identified as an emerging risk factor
for adverse cardiovascular (CV) outcomes, including heart failure. However, the connections …

BACKGROUND: Aortic valve calcification (AVC), Lp (a)[lipoprotein (a)], and low-density
lipoprotein cholesterol (LDL-C) are associated with severe aortic stenosis (AS). We aimed to …

Lipoprotein(a) and calcific aortic valve disease: current ev... : Current Opinion in Clinical
Nutrition & Metabolic Care Lipoprotein(a) and calcific aortic valve disease: current evidence …

Background Valvular heart disease poses an escalating global health challenge with an
increasing impact on mortality and disability. This study aims to comprehensively analyze …

Abstract Background and Aims Physical activity has proven effective in preventing
atherosclerotic cardiovascular disease, but its role in preventing degenerative valvular heart …

Abstract Background: Histidine-tryptophan-ketoglutarate (HTK) cardioplegia induces cardiac
arrest through membrane hyperpolarization. Aortic valve pathology leads to …

The pathological mechanisms underlying the sex-dependent presentation of calcific aortic
stenosis (AS) remain poorly understood. We aim to analyse sex-specific responses of valve …

Background Despite the essential role of ectopic osteogenic calcium-phosphate metabolism
in the development of calcific aortic valve disease (CAVD), the implications of high serum …

Background Aortic valve calcification (AVC) is prognostic in patients with aortic stenosis
(AS). We assessed the AVC prognostic value in nonsevere AS patients. Methods and …

Background Cardiovascular diseases, such as aortic valve calcification (AVC) and carotid
atherosclerosis (CAS), impose substantial health challenges on a global scale. Both …